NCT04825431View on ClinicalTrials.gov

Mass Balance Study of [14C] TAS-205 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

June 15, 2021

Study Completion Date

May 27, 2022

Conditions
Healthy Male Subjects
Interventions
DRUG

TAS-205, [14C]TAS-205

single oral administration under fasted conditions on day 1

Trial Locations (1)

Unknown

A site selected by Taiho Pharmaceutical Co., Ltd., Tokyo

All Listed Sponsors
lead

Taiho Pharmaceutical Co., Ltd.

INDUSTRY

NCT04825431 - Mass Balance Study of [14C] TAS-205 in Healthy Volunteers | Biotech Hunter | Biotech Hunter